{"changes":[],"country":"US","description":"Maze Therapeutics develops small-molecule precision medicines for renal, cardiovascular, and metabolic diseases, including obesity. It serves patients with chronic kidney disease, led by MZE829 for APOL1 kidney disease and MZE782. Its Compass platform links genetic variants to disease pathways so therapies match genetically defined patient groups.","domain":"mazetherapeutics.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"biotech|therapeutics|metabolic","investors":[],"lat":37.65354,"lng":-122.416866,"location":"South San Francisco CA","name":"Maze Therapeutics","rounds":[{"amountQuarantined":false,"amountUsd":115000000,"currency":"USD","date":"2024-12-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"series-d+","url":null}],"slug":"mazetherapeutics-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"mazetherapeutics.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://mazetherapeutics.com"},{"fact":"description","publisher":"mazetherapeutics.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://mazetherapeutics.com"}],"stage":"series-b+","techStack":[],"totalRaisedUsd":115000000,"updatedAt":"2026-05-07"}